Literature DB >> 16630658

Differences in epidemiology of MDS between Western and Eastern countries: Ethnic differences or environmental influence?

Andrea Kuendgen1, Akira Matsuda, Ulrich Germing.   

Abstract

Myelodysplastic syndromes show ethnic differences. Several investigators have reported a striking difference in age at diagnosis between Eastern and Western MDS patients. Referring to a letter bei Paydas speculating about toxic environmental influences as a possible cause for younger age in Asian MDS patients, we discuss our experience from a direct comparison of Japanese and German MDS, in particular refractory anemia patients.

Entities:  

Mesh:

Year:  2006        PMID: 16630658     DOI: 10.1016/j.leukres.2006.03.007

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  Prospective analysis of clinical and cytogenetic features of 435 cases of MDS diagnosed using the WHO (2001) classification: a prognostic scoring system for predicting survival in RCMD.

Authors:  Xiao Qin Wang; John Ryder; Sherilyn A Gross; Guowei Lin; Richard D Irons
Journal:  Int J Hematol       Date:  2009-08-29       Impact factor: 2.490

2.  The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes.

Authors:  Michaela Cada; Catherin I Segbefia; Robert Klaassen; Conrad V Fernandez; Rochelle A Yanofsky; John Wu; Yves Pastore; Mariana Silva; Jeffrey H Lipton; Josee Brossard; Bruno Michon; Sharon Abish; MacGregor Steele; Roona Sinha; Mark Belletrutti; Vicky Breakey; Lawrence Jardine; Lisa Goodyear; Lillian Sung; Mary Shago; Joseph Beyene; Preeti Sharma; Bozana Zlateska; Yigal Dror
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

Review 3.  Chinese guidelines for treatment of adult primary immune thrombocytopenia.

Authors:  Xin-Guang Liu; Xiao-Chuan Bai; Fang-Ping Chen; Yun-Feng Cheng; Ke-Sheng Dai; Mei-Yun Fang; Jian-Ming Feng; Yu-Ping Gong; Tao Guo; Xin-Hong Guo; Yue Han; Luo-Jia Hong; Yu Hu; Bao-Lai Hua; Rui-Bing Huang; Yan Li; Jun Peng; Mi-Mi Shu; Jing Sun; Pei-Yan Sun; Yu-Qian Sun; Chun-Sen Wang; Shu-Jie Wang; Xiao-Min Wang; Cong-Ming Wu; Wen-Man Wu; Zhen-Yu Yan; Feng-E Yang; Lin-Hua Yang; Ren-Chi Yang; Tong-Hua Yang; Xu Ye; Guang-Sen Zhang; Lei Zhang; Chang-Cheng Zheng; Hu Zhou; Min Zhou; Rong-Fu Zhou; Ze-Ping Zhou; Hong-Li Zhu; Tie-Nan Zhu; Ming Hou
Journal:  Int J Hematol       Date:  2018-04-04       Impact factor: 2.490

4.  Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.

Authors:  Masatoshi Matsuo; Masako Iwanaga; Hisayoshi Kondo; Midori Soda; Tatsuro Jo; Kensuke Horio; Yumi Takasaki; Yasuhisa Kawaguchi; Hideki Tsushima; Yoshitaka Imaizumi; Daisuke Imanishi; Jun Taguchi; Yasushi Sawayama; Tomoko Hata; Yasushi Miyazaki
Journal:  Cancer Sci       Date:  2016-09-02       Impact factor: 6.716

5.  Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems.

Authors:  Özlen Bektaş; Ayşegül Üner; Eylem Eliaçık; Burak Uz; Ayşe Işık; Sezgin Etgül; Süreyya Bozkurt; İbrahim Celalettin Haznedaroğlu; Hakan Göker; Nilgün Sayınalp; Salih Aksu; Haluk Demiroğlu; Osman İlhami Özcebe; Yahya Büyükaşık
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

6.  Clinical Prognostic Factors in 86 Chinese Patients with Primary Myelodysplastic Syndromes and Trisomy 8: A Single Institution Experience.

Authors:  Qing Fang Yue; Lei Chen; Xiao Mei She; Bin Hu; Yu Hu; Ping Zou; Xin Yue Liu
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

7.  Clinico-Pathological Spectrum and Novel Karyotypic Findings in Myelodysplastic Syndrome: Experience of Tertiary Care Center in India.

Authors:  Ruchi Gupta; Khaliqur Rahman; Manish Kumar Singh; Surabhi Kumari; Geeta Yadav; Soniya Nityanand
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-08-16       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.